Skip to main content

AmbAgon Therapeutics

San Francisco, United States

AmbAgon Therapeutics is a developer of cancer molecule therapeutics.

$5.0M raised
Feb 2025
Venture - Series Unknown

Top Investors

AbbVieRA Capital ManagementInkefMission BioCapitalMRL Ventures Fund

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AmbAgon Therapeutics

How much funding has AmbAgon Therapeutics raised?
AmbAgon Therapeutics has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
Who are AmbAgon Therapeutics's investors?
AmbAgon Therapeutics's investors include AbbVie, RA Capital Management, Inkef, Mission BioCapital, MRL Ventures Fund.
Where is AmbAgon Therapeutics headquartered?
AmbAgon Therapeutics is headquartered in San Francisco, United States.
What does AmbAgon Therapeutics do?
AmbAgon Therapeutics is a developer of cancer molecule therapeutics.
What stage is AmbAgon Therapeutics at?
AmbAgon Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"AmbAgon Therapeutics — Funding & Investors." VCBacked, February 7, 2025, https://www.vcbacked.co/company/ambagon-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). AmbAgon Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ambagon-therapeutics
Wikipedia (cite web)
{{cite web |title=AmbAgon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ambagon-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .